HK1101136A1 - Compositions against sars-coronavirus and uses thereof - Google Patents
Compositions against sars-coronavirus and uses thereofInfo
- Publication number
- HK1101136A1 HK1101136A1 HK07109226.0A HK07109226A HK1101136A1 HK 1101136 A1 HK1101136 A1 HK 1101136A1 HK 07109226 A HK07109226 A HK 07109226A HK 1101136 A1 HK1101136 A1 HK 1101136A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- coronavirus
- compositions against
- against sars
- sars
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62777304P | 2004-11-11 | 2004-11-11 | |
EP04105684 | 2004-11-11 | ||
EP04106192 | 2004-11-30 | ||
EP05102117 | 2005-03-17 | ||
EP05107288 | 2005-08-08 | ||
PCT/EP2005/055876 WO2006051091A1 (en) | 2004-11-11 | 2005-11-10 | Compositions against sars-coronavirus and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1101136A1 true HK1101136A1 (en) | 2007-10-12 |
Family
ID=34929841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07109226.0A HK1101136A1 (en) | 2004-11-11 | 2007-08-24 | Compositions against sars-coronavirus and uses thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101102794B (en) |
HK (1) | HK1101136A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115151824A (en) * | 2020-02-28 | 2022-10-04 | 南京金斯瑞生物科技有限公司 | SARS-CoV-2 virus detection method and detection reagent kit |
CN114163523B (en) * | 2020-03-17 | 2023-07-18 | 北京凯因科技股份有限公司 | Single-domain antibody for novel coronavirus and application thereof |
CN111289744A (en) * | 2020-03-17 | 2020-06-16 | 长春万成生物电子工程有限公司 | Novel colloidal gold test paper for coronavirus detection |
CN112946294B (en) * | 2020-04-02 | 2024-03-15 | 长春西诺生物科技有限公司 | Novel coronavirus 2019-nCoV antibody detection test strip and preparation method and application thereof |
WO2021244601A1 (en) * | 2020-06-04 | 2021-12-09 | 山东博安生物技术股份有限公司 | Neutralizing antibody of sars-cov-2 virus and application thereof |
CN113945714B (en) * | 2020-07-16 | 2023-01-31 | 南京蓬勃生物科技有限公司 | Method for detecting neutralizing capacity of novel coronavirus neutralizing antibody drugs |
CN116693671A (en) * | 2020-07-20 | 2023-09-05 | 福建医科大学附属协和医院 | Novel coronavirus neutralizing antibody, and preparation method and application thereof |
WO2022233321A1 (en) * | 2021-05-07 | 2022-11-10 | 百奥泰生物制药股份有限公司 | Coronavirus antibody and use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1184319C (en) * | 2003-06-13 | 2005-01-12 | 李越希 | Chemosynthesized SARS virus S gene segement, its expression and application |
CN1465589A (en) * | 2003-06-17 | 2004-01-07 | 中国医学科学院血液学研究所 | Gene recombination SARS virus coat protein S and preparation process thereof |
-
2005
- 2005-11-10 CN CN200580038709XA patent/CN101102794B/en not_active Expired - Fee Related
-
2007
- 2007-08-24 HK HK07109226.0A patent/HK1101136A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101102794A (en) | 2008-01-09 |
CN101102794B (en) | 2012-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI369981B (en) | Hmb compositions and uses thereof | |
EP1895838A4 (en) | Compositions and methods | |
EP1802588A4 (en) | Substituted amino-pyrimidones and uses thereof | |
HK1099927A1 (en) | Levodopa derivatives, and compositions and uses thereof | |
ZA200704295B (en) | Arthrospira-based compositions and uses thereof | |
PT1883665T (en) | Polylactide compositions and uses thereof | |
EP1874348A4 (en) | Immunomodulating compositions and uses therefor | |
ZA200700809B (en) | Corrosion-inhibiting compositions and use thereof | |
GB0522287D0 (en) | Method and compositions | |
IL179497A0 (en) | Carboranylporphyrins and uses thereof | |
IL182126A (en) | Compositions containing 5-phenoxyalkoxypsoralen derivatives and uses thereof | |
EP1848438A4 (en) | Diaminophenothiazine compositions and uses thereof | |
HK1101136A1 (en) | Compositions against sars-coronavirus and uses thereof | |
IL184062A0 (en) | Visco-supplement composition and methods | |
IL180365A0 (en) | Carboranylporphyrins and uses thereof | |
EP1807071A4 (en) | Antipyretic compositions and methods | |
EP1737458A4 (en) | R(-)-11-hydroxyaporphine derivatives and uses thereof | |
GB0524927D0 (en) | Compositions and method | |
GB0513431D0 (en) | Prophylactic compositions and uses | |
GB0424051D0 (en) | Compounds and compositions | |
GB0501348D0 (en) | Compositions and methods | |
GB0325942D0 (en) | Compositions and uses thereof | |
ZA200706038B (en) | Visco-supplement composition and methods | |
GB0511235D0 (en) | Compositions and method | |
EP1824502A4 (en) | Compositions comprising sclareol or derivatives thereof and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20171110 |